Becton Dickinson
In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More
News items for the in vitro diagnostic industry for the week of Sept. 20, 2021.
The Delta variant of SARS-CoV-2 has boosted COVID-19 testing, but the severity of the coming flu season and the need for combo tests remain unpredictable.
BD Gets FDA Emergency Authorization for At-Home Smartphone-Read COVID-19 Antigen Test
The over-the-counter test uses a smartphone app to read, analyze, and interpret the results of a SARS-CoV-2 rapid antigen test.
FDA Approves BD High-Throughput Cor System, HPV Screening Assay
The modular and scalable system was approved with the firm's assay to detect 14 high-risk types of human papillomavirus.
BD, CerTest Biotec Get CE Mark for SARS-CoV-2 Variant MDx
The test runs on the BD Max PCR system and detects the Alpha, Beta, and Gamma strains of the SARS-CoV-2 virus.
Feb 17, 2021
Feb 4, 2021